M48. IS METABOLIC SYNDROME RELATED TO COGNITIVE PERFORMANCE IN PATIENTS WITH SCHIZOPHRENIA? RESULTS FROM A DOUBLE-BLIND, ACTIVE-CONTROLLED, LURASIDONE STUDY

BACKGROUND: Schizophrenia is associated with cognitive dysfunction as well as cardiovascular disease (CVD). A central risk factor for CVD is the metabolic syndrome (MetS), which is of special concern in schizophrenia. The prevalence of MetS in U.S. patients with schizophrenia is higher versus genera...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Schizophr Bull
Hlavní autoři: Hagi, Katsuhiko, Nosaka, Tadashi, Pikalov, Andrei
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2020
Témata:
Poster Session II
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7234130/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbaa030.360
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky